RI-MUHC Annual Report

YEAR IN REVIEW

CARDIOVASCULAR HEALTH ACROSS THE LIFESPAN (CHAL) PROGRAM

RESEARCH HIGHLIGHTS

Personalizing cardiovascular health

Co-led by Drs. Nadia Giannetti and Matthias Friedrich, the Courtois Cardiovascular Signature Program is a new study aiming to personalize cardiovascular health, based on each person’s unique combination of genetic, microbiotic, environmental and other factors. (cvsignature.ca)

New tools to identify patients with familial hypercholesterolemia

Dr. Jacques Genest leads the Canadian Familial Hypercholesterolemia Registry, contributing to new Canadian guidelines for diagnosis and treatment of familial hypercholesterolemia and development of the first Clinical Laboratory Improvement Amendments-certified genetic diagnostic test in Canada. These advances will improve the identification and care of patients with this disorder and reduce cardiovascular disease in this high-risk population. (FH Canada)

Assessing the effect of gender on clinical outcomes

Dr. Louise Pilote leads a data science and personalized medicine project, the Gender Outcomes INternational Group: to Further Well-being Development (GOING-FWD). This transatlantic network has developed and applied an innovative and timely framework for assessing the effect of gender on clinical outcomes. (GOING-FWD)

Drs. Nadia Giannetti, Matthias Friedrich, Jacques Genest and Louise Pilote
Drs. Nadia Giannetti, Matthias Friedrich, Jacques Genest and Louise Pilote

Selected CHAL Program news links

rimuhc.ca/CHAL